Closed · HT9425-23-TERP-CTA · CFDA 12.420 · Discretionary

DOD Toxic Exposures, Clinical Trial Award

Federal grant opportunity posted by Dept. of the Army -- USAMRAA, cataloged on Grants.gov.

Varies
Award range
Closed
Status
October 4, 2023
Close date
3
Expected awards

The verdict

DOD Toxic Exposures, Clinical Trial Award is a closed discretionary listing from Dept. of the Army -- USAMRAA that offered Varies by applicant across 3 expected awards. Future funding cycles may be published under the same CFDA number.

Varies
award range
Closed
application status
3
expected awards
12.420
CFDA program

Opportunity snapshot. This Grants.gov announcement - DOD Toxic Exposures, Clinical Trial Award - is cataloged under number HT9425-23-TERP-CTA and tied to CFDA assistance listing 12.420, posted by Dept. of the Army -- USAMRAA. Grants.gov currently shows the opportunity as closed, first posted on July 7, 2023. The funding category is Discretionary, delivered as a grant.

Award economics. The award range on file is Varies by applicant. The agency has projected $8.8 million in total estimated funding for this announcement. It expects to issue 3 awards. If the agency funds the expected 3 awards from the $8.8 million estimated pool, the average award works out to roughly $2.9 million. Cost sharing is not required, so applicants do not need to commit matching funds to be competitive on this opportunity. Federal award ranges are often upper bounds; actual allocations reflect program appropriations, the strength of the applicant pool, and the evaluation committee's scoring.

Deadline and action path. This opportunity closed on October 4, 2023. Future funding cycles may be published under the same CFDA number, so monitoring the parent program page is the most reliable way to catch re-announcements. Every Grants.gov submission requires an active SAM.gov registration and a Unique Entity ID. Review the Eligibility section below carefully, federal eligibility categories (nonprofit, state or local government, tribal, individual, educational institution, small business) have distinct registration and reporting requirements. Pre-application outreach to the listed agency contact is permitted and often welcomed, it helps clarify scope and scoring priorities. Before acting on the deadline or award figures above, verify them directly on the official Grants.gov listing, amendments can change dates and amounts after this page was last refreshed.

Award Range

Varies by applicant

Close Date

October 4, 2023

Posted

July 7, 2023

Est. Total Funding

$8,800,000

Expected Awards

3

Instrument

Grant

Description

The TERP CTA supports the rapid implementation of clinical trials with the potential to have a significant impact on the prevention, treatment, or management of symptoms, diseases, or conditions associated with or resulting from military-related toxic exposures. To meet the intent of the award mechanism, applications must address at least one of the FY23 TERP Programmatic Goals and at least one of the FY23 TERP Topic Areas.Proposed projects may range from small proof-of-concept clinical trials (e.g., pilot, first-in-human, phase 0) designed to demonstrate the feasibility or inform the design of more advanced trials through large-scale trials to determine efficacy in relevant patient populations. Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance, and/or emerging approaches and technologies. It is anticipated that outcomes from studies funded by this award will follow a clinical development plan that advances the research to U.S. Food and Drug Administration (FDA) device or drug approval and/or establishment of clinical practice guidelines, as applicable.Applications to the TERP CTA mechanism must support a clinical trial and may not be used for animal or other preclinical research studies. The application will be withdrawn if the proposed research is not a clinical trial.

Eligibility

Grants.gov lists this opportunity under eligibility category code 99. These codes correspond to applicant types (state/local government, tribal organization, nonprofit, educational institution, individual, small business, etc.) defined in Grants.gov's own eligibility reference. See the current Grants.gov eligibility categories or check the official listing below for this opportunity's exact eligibility statement.

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

CDMRP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org

Key Dates

Posted July 7, 2023
Close Date October 4, 2023
Archive Date November 3, 2023
Last Updated July 7, 2023

Frequently Asked Questions

What is this grant opportunity?
This is a federal funding opportunity titled "DOD Toxic Exposures, Clinical Trial Award", offered by Dept. of the Army -- USAMRAA. It is associated with CFDA program 12.420. The TERP CTA supports the rapid implementation of clinical trials with the potential to have a significant impact on the prevention, treatment, or management of symptoms, diseases, or conditions assoc...
Is this opportunity still open?
No, this opportunity is closed. It closed on October 4, 2023. Check the parent program page for future funding cycles.
How much funding is available?
The award range for this opportunity is Varies by applicant. Total estimated funding: $8,800,000. Expected number of awards: 3.
How do I apply?
Applications for federal grant opportunities are typically submitted through Grants.gov. Visit the official listing at grants.gov for application instructions, required documents, and submission deadlines.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Data sourced from the SAM.gov Assistance Listings and Grants.gov. See our methodology for details. Retrieved and formatted by PlainGrants